TWIST1 and breast carcinoma: The diagnostic efficacy of lncATB (AUC = 0.851, P < 0.001, Fig. 7c) and Twist1 (AUC = 0.778, P = 0.001, Fig. 7f) in breast cancer patients was evaluated by calculating the area under the receiver operating characteristic (ROC) curve.